Intraoperative Sufentanil and chronic postsurgical pain in non-major scheduled abdominal surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510140-21-00

Acronym

PI2023_843_0173

Enrollment

855

Registered

2024-03-22

Start date

2024-06-24

Completion date

Unknown

Last updated

2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic postsurgical pain in non-major scheduled abdominal surgery

Brief summary

Incidence of CPSP at 3 months after non-major scheduled abdominal surgery

Detailed description

Post-operative pain intensity assessed by NRS of 11 points at 24 hours and 48 hours after operating room discharge, Time taken until the use of 3rd step analgesics, Consumption of opioid derivatives and opioids at 24 hours, 48 hours and 3 months after surgery, CPSP intensity at 3 months and neuropathic pain incidence at 3 months.

Interventions

DRUGSUFENTANIL

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Incidence of CPSP at 3 months after non-major scheduled abdominal surgery	—

Secondary

Measure	Time frame
Post-operative pain intensity assessed by NRS of 11 points at 24 hours and 48 hours after operating room discharge, Time taken until the use of 3rd step analgesics, Consumption of opioid derivatives and opioids at 24 hours, 48 hours and 3 months after surgery, CPSP intensity at 3 months and neuropathic pain incidence at 3 months.	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026